基本信息
浏览量:0
职业迁徙
个人简介
Caseswill also be followed to gain information on the natural history of thisdisease including risk factors for progression of disease. A steeringcommittee will develop a protocol and manual of operations which willaddress the most promising hypotheses to be pursued to identify thecauses of sarcoidosis. The protocol will include a comprehensiveclinical characterization of each participant and determination of markersof immune responsiveness.
His major research interests include two major clinic areas: the treatment of sarcoidosis and the diagnosis of pneumonia. Along with his long time collaborator Dr. Elyse Lower, he has developed several novel treatments for sarcoidosis, including methotrexate, thalidomide, leflunomide, and infliximab. Current studies include treatments for sarcoidosis associated fatigue and pulmonary hypertension due to sarcoidosis.
研究兴趣
论文共 475 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Journal of Autoimmunitypp.103179-103179, (2024)
Respiratory medicine (2024): 107605-107605
Clinics in Chest Medicineno. 1 (2024): xiii-xiii
CLINICS IN CHEST MEDICINEno. 1 (2024): 119-129
Expert review of clinical immunologyno. 1 (2024): 59-70
Shameek K. Gayen,Robert P. Baughman,Steven D. Nathan,Athol U. Wells,Vasilis Kouranos,Esam H. Alhamad,Daniel A. Culver,Joseph Barney, Eva M. Carmoma,Francis C. Cordova,Marloes Huitema,Mary Beth Scholand,Marlies Wijsenbeek,Sivagini Ganesh,Surinder S. Birring,Laura C. Price,Stephen J. Wort,Oksana A. Shlobin,Rohit Gupta
Pulmonary circulationno. 4 (2023)
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOGno. 4 (2023): e2023047-e2023047
Abhijeeth Chandrasekaran,Nelson Kinnersley, Pavithra Ramesh,Vis Niranjan,Sanjay Shukla,Robert P. Baughman
EUROPEAN RESPIRATORY JOURNAL (2023)
加载更多
作者统计
#Papers: 521
#Citation: 26052
H-Index: 81
G-Index: 151
Sociability: 7
Diversity: 3
Activity: 88
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn